Century Therapeutics (IPSC) Current Leases (2022 - 2025)
Historic Current Leases for Century Therapeutics (IPSC) over the last 4 years, with Q2 2025 value amounting to $4.9 million.
- Century Therapeutics' Current Leases rose 3360.63% to $4.9 million in Q2 2025 from the same period last year, while for Jun 2025 it was $4.9 million, marking a year-over-year increase of 3360.63%. This contributed to the annual value of $4.9 million for FY2024, which is 22187.71% up from last year.
- Latest data reveals that Century Therapeutics reported Current Leases of $4.9 million as of Q2 2025, which was up 3360.63% from $4.9 million recorded in Q1 2025.
- Century Therapeutics' Current Leases' 5-year high stood at $4.9 million during Q2 2025, with a 5-year trough of $475000.0 in Q4 2022.
- Moreover, its 4-year median value for Current Leases was $3.7 million (2024), whereas its average is $3.1 million.
- In the last 5 years, Century Therapeutics' Current Leases surged by 22187.71% in 2024 and then soared by 3360.63% in 2025.
- Century Therapeutics' Current Leases (Quarter) stood at $475000.0 in 2022, then soared by 218.53% to $1.5 million in 2023, then soared by 221.88% to $4.9 million in 2024, then increased by 0.49% to $4.9 million in 2025.
- Its Current Leases stands at $4.9 million for Q2 2025, versus $4.9 million for Q1 2025 and $4.9 million for Q4 2024.